Immunotec moves up to 76th on the DSN Global 100

Rezul News/10418399
HOUSTON - May 3, 2019 - Rezul -- Two years after being purchased by the company's CEO, Mauricio Domenzain, in partnership with Nexxus Capital, one of the leading alternative asset managers in Mexico, Immunotec achieved its highest-ever placement on the DSN Global 100—number 76—as announced at the tenth anniversary of the Direct Selling News Global 100 awards held in Dallas, Texas.
Commenting on Immunotec's higher placement on the Global 100, Mr. Domenzain said: "I want to extend a heartfelt thank you and congratulations to all who worked so hard as a team to make this happen. This achievement is a reflection of the hard work, passion, and commitment of our consultants, customers, and corporate team combined with our best-in-class science-based products. We are now fully focused on what we need to do to make Immunotec the best direct selling company in the world, and our position on the DSN Global 100 tells us we're moving in the right direction, fast."

More on Rezul News
With offices in Houston, Texas, Mexico City, and Montreal, Canada, where the company was founded, Immunotec develops, manufactures, markets, and sells science-based nutritional products, anchored by flagships Immunocal and Immunocal Platinum, through its fast-growing network of independent consultants in Canada, Colombia, the Dominican Republic, Guatemala, Ireland, Mexico, the United Kingdom, and the United States.

Visit us at

Dave Farrant

Source: Immunotec
Show All News | Report Violation

1000 characters max.